HPV/Human Papillomavirus Diagnostics Market: US, Europe, Japan

Venture Planning Group (www.VPGMarketResearch.com) is pleased to announce completion of a new report, "HPV/Human Papillomavirus Diagnostics Market: US, Europe, Japan."
 
Oct. 26, 2011 - PRLog -- Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to announce the completion of a new  report, "HPV/Human Papillomavirus Diagnostics Market: US, Europe, Japan."
(http://www.vpgmarketresearch.com/infectious-diseases.html?sType=&sField=&id=&page=37). The report provides industry executives with strategically significant competitor information and analysis of the leading players in the HPV/Human Papillomavirus Diagnostics Market.

The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

    - Hospitals
    - Commercial/Private Labs
    - Physician Offices
    - Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Papillomavirus tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 196 pages and 10 tables

To review or order this report, please visit
http://www.vpgmarketresearch.com/Papillomavirus-Diagnosti...

To review related reports, please visit
http://www.VPGMarketResearch.com

Contact
Diagnostic Industry Market Research
Robert Fisher
robert@vpgcorp.com
+1 212 564 2838

# # #

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavors & Fragrances, Food & Beverage, Electronics, and other industries.

During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of worldwide contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

Specialties
Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/Joint Venture Evaluations.
End
Source: » Follow
Email:***@vpgcorp.com Email Verified
Zip:10018
Tags:Hpv, Human Papilloma Virus, Cervical Cancer, Hpv Vaccine
Industry:Biotech, Business, Reports
Location:New York City - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share